Insulin-like growth factor: current concepts and new developments in cancer therapy.
about
The Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapySpecificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerIGF-IR Targeted Therapy: Past, Present and FutureNovel tools for prostate cancer prognosis, diagnosis, and follow-upUpdate of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapyEngineered ubiquitin ligase PTB-U-box targets insulin/insulin-like growth factor receptor for degradation and coordinately inhibits cancer malignancyInsulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer.The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysisTargeting the insulin-like growth factor-1 receptor in human cancer.Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease.Preclinical and first-in-human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with insulin-like growth factor receptor-1/insulin receptor selectivityIdentification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic targetBuilding the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?Targeting IGF-1 signaling pathways in gynecologic malignancies.A review of treatment of uterine leiomyosarcomas.The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey.Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks TumorigenesisHyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management.In vivo evaluation of IGF1R/IR PET ligand [18F]BMS-754807 in rodents.In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer.Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.Insulin mediates de novo nuclear accumulation of the IGF-1/insulin Hybrid Receptor in corneal epithelial cells.The role of some ADAM-proteins and activation of the insulin growth factor-related pathway in colorectal cancer.
P2860
Q26777125-AD1629E5-FCA8-4CE3-8A79-072B8491C545Q26853171-E49D4CEB-5F60-44FD-8545-00656264C242Q28082127-DC25C586-D457-4928-BA87-7ED5B7E9CBF7Q33625338-24D606BB-C5D8-4A90-9782-4F128C625FDBQ33710179-C6C43978-9B76-4C1A-8EC0-F068172FFA74Q34104101-15C2834E-5AE7-4212-81F7-2B981E730531Q34391968-788FF63F-4900-471E-86BB-E794E9D2B29EQ34532397-F3C0EAF2-EED3-4537-BE86-963BEFEA9C20Q34664129-931A32D3-3806-4E49-B7C6-F4FFE3F2B4B9Q35030616-3C634B9B-4159-4874-889D-8E9819C5235AQ35753660-5606D188-E1E2-4DE7-996C-5909A9760FB2Q36708178-F4D1541A-90C4-495C-9C59-6F46E3A998D9Q36750001-237EB628-E94A-4816-963E-6DECACC7B32CQ36801184-E94E2DE4-B3A8-4E2F-8002-12DD0E85A73EQ37207654-0C5B2A84-18A2-4535-A404-FDA73767F4C2Q37550127-95BA7AA6-4F59-4AD2-A825-CFE1D4A6178AQ37636467-4AC91D80-773A-4E0F-A3CF-07CF6D2F6110Q38072115-2BCEE957-FC59-4D32-B169-CB5F8A78AB90Q38153648-F94BD73E-7B8B-4E5B-9749-14BF76B19E9AQ38210070-A24EE5F5-6308-44C0-8281-3218E05C5E12Q38709499-E96F48FD-76D2-4A9C-A19A-668222E6C1E3Q38726530-1FD82025-50F0-4C8C-8323-26DF29F2CD20Q38912656-1459E90E-F6ED-44CB-A81E-B40B60747394Q39017291-D220A1B7-A3DE-4160-B617-2E97965858B5Q39068603-25BA45B1-CE23-40D7-9A95-3E20D69E2731Q39580270-7E638FCE-70EF-4486-82A6-3A8A69358EA3Q46237958-4D33538F-D0E8-451F-B4AF-1F4298F07CBDQ48088749-636BA57B-17BE-4AB8-A7BE-A446699A4B5DQ51741045-9315D979-E0FB-4DCE-B574-DB3B9A666558Q53687233-06D443F1-FD23-4CBB-8EB0-F46645476B80
P2860
Insulin-like growth factor: current concepts and new developments in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@en
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@nl
type
label
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@en
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@nl
prefLabel
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@en
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@nl
P2860
P1476
Insulin-like growth factor: current concepts and new developments in cancer therapy.
@en
P2093
Erin R King
Kwong-Kwok Wong
P2860
P356
10.2174/157489212798357930
P577
2012-01-01T00:00:00Z